- Glenview Capital Management’s 13F portfolio value increased from ~$5.08B to ~$5.17B this quarter.
- They increased CVS Health (CVS) and Global Payments (GPN) while reducing Tenet Healthcare (THC), Cigna (CI), and Universal Health Services (UHS).
- The top three individual stock stakes are CVS Health (CVS), Tenet Healthcare (THC), and Global Payments (GPN). They add up to ~31% of the portfolio.
This article is part of a series that provides an ongoing
analysis of the changes made to Larry Robbins’ 13F portfolio on a quarterly
basis. It is based on Robbins’ regulatory 13F Form filed on 11/14/2024. Please
visit our Tracking
Larry Robbins’ Glenview Capital Management Portfolio article for an idea on
his investment philosophy and our previous
update for the fund’s moves during Q2 2024.
This quarter, Robbins’ 13F portfolio value increased from
~$5.08B to ~$5.17B. There are 27 positions that are significantly large. The
spreadsheet below lists those larger positions individually. The top five
individual stock stakes are CVS Health (CVS), Tenet Healthcare (THC), Global
Payments (GPN), Cigna (CI), and Corteva (CTVA). Together they are at ~44% of
the 13F assets.
To learn about individual investing, check out the classics The Intelligent Investor and Security Analysis.
The spreadsheet below highlights changes to Robbins’ 13F
stock holdings in Q3 2024:
Source: John Vincent. Data constructed from Glenview Capital
Management’s 13F filings for Q2 2024 and Q3 2024.
No comments :
Post a Comment